Breaking News from Sweden, Business

from Bing and Google News
Sweden , Wednesday 15 April 2026

The Swedish Medical Products Agency Approves New Treatment Arm With Remygen® and Alprazolam in Phase I/II Trial ReGenerate-1

Published on: Wednesday 29 May 2019

FNCA Sweden AB is the Company's Certified Adviser; phone: +46-8-528-00-399 e-mail: [email protected]. Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. ...


News source: https://markets.businessinsider.com/news/stocks/the-swedish-medical-products-agency-approves-new-treatment-arm-with-remygen-and-alprazolam-in-phase-i-ii-trial-regenerate-1-1028238962

Share this news on:  

RELATED NEWS

» Sweden wants to be the first country to trademark its name: 'We'd prefer if there were only one'
» Tesla Cars Show Potential For Wider Business Use
» The Surgical Science Sweden (STO:SUS) Share Price Has Gained 279%, So Why Not Pay It Some Attention?
» Swedish Defence Firm Saab's CEO to Step Down
» ASAP Rocky's Mom on Her Son's Imprisonment in Sweden: 'It's So Unjust'

HEADLINE NEWS